Provided by Tiger Fintech (Singapore) Pte. Ltd.

AIM ImmunoTech Inc.

9.21
+0.910010.96%
Post-market: 9.210.00000.00%19:52 EDT
Volume:87.17K
Turnover:910.13K
Market Cap:7.04M
PE:-0.37
High:10.38
Open:9.13
Low:8.50
Close:8.30
Loading ...

AIM Gets US FDA Clinical Trial Approval for Herpes Zoster Vaccine; Shares Up 8%

MT Newswires Live
·
24 Mar

Wellnex Life Secures AIM Listing on London Stock Exchange

MT Newswires Live
·
24 Mar

Octopus AIM VCT 2 Announces Share Buyback and Voting Rights Update

TIPRANKS
·
21 Mar

AIM IPOs offer glimpse of recovery for junior stock exchange

cityam
·
17 Mar

U.K.'s MHA Plans IPO on London's AIM, Seeking to Raise Up to $162 Mln

Dow Jones
·
17 Mar

Wellnex Life Reports 89% Revenue Surge in Early 2025 as AIM Listing Nears

MT Newswires Live
·
17 Mar

AIM Vaccine Reports Significant Reduction in Annual Losses

TIPRANKS
·
17 Mar

Hornby to Seek Shareholder Approval to Cancel AIM Listing

Dow Jones
·
13 Mar

AIM Vaccine's Subsidiary's Rabbies Vaccine Clears Phase III, Marketing Registration Application Submitted

MT Newswires Live
·
12 Mar

AIM Vaccine Advances with Breakthrough Serum-Free Rabies Vaccine

TIPRANKS
·
12 Mar

Number of AIM-listed firms sinks to lowest level since 2001

cityam
·
12 Mar

Chemours Joins University of Kansas-Led Collaborative the Environmentally Applied Refrigerant Technology Hub (EARTH) To Advance Sustainable Cooling Technologies

ACCESS Newswire
·
11 Mar

Unicorn AIM VCT PLC Issues New Shares to Raise Capital

TIPRANKS
·
11 Mar

AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

GlobeNewswire
·
11 Mar

Octopus AIM VCT 2 Reports Resilient Performance Amid Market Challenges

TIPRANKS
·
11 Mar

RA International Announces Secondary Trading Facility Post-AIM Cancellation

TIPRANKS
·
11 Mar

City group in talks over AIM transformation plan

cityam
·
10 Mar

Coherent Announces Launch of AIM Family of Industrial, Rack-Based Multi-Kilowatt Single Mode Fiber Lasers

GlobeNewswire
·
10 Mar

AIM Vaccine's Rabbies Vaccine Gets NMPA Nod for Clinical Trials; Shares Slide 17%

MT Newswires Live
·
10 Mar

AIM Vaccine Secures Approval for Advanced Rabies Vaccine, Bolstering Global Market Position

TIPRANKS
·
09 Mar